Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by BearDownAZon Apr 05, 2017 3:25pm
127 Views
Post# 26081513

RE:RE:RE:RE:CHINA TRIAL STATUS?

RE:RE:RE:RE:CHINA TRIAL STATUS?Toniv wrote "Given that any company can buy and test apabetalone I am somewhat surprised that Hepalink is not (or apparently not) doing their own testing."

Yes, there are companies that are licensed/approved by Resverlogix to sell non-pharmacutical grade (not for human use) apabetalone for research purposes only. Many companies with compounds in clinical trials do this. We've discussed this on this board before.

However, the amount of apabetalone needed for a cell culture study or a short-term pre-clinical study in a small animal model (i.e. mouse) is very small relative to the amount needed for a humans. Apabetalone in SUSTAIN, ASSURE and BETonMACE is given at 100 mg twice a day. That's 200 mg per patient per day. Out of eight companies I scanned online, the cheapest out of BioVision, Cayman Chemicals, MedChem Express, SantaCruz, MedKoo Biosciences, SeleckChem, Toronto Research Chemicals, and APExBIO, the cheapest I found was 50 mg for $350 USD. Do the math and you'll find that it is not practical to purchase apabetalone from one of these companies for a human study. Plus, it is likely not pharmaceutical grade and likely not meeting Current Good Manufacturing Practice (cGMP) requirements.
 
BDAZ
Bullboard Posts